Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Glucagon-like peptide 1 receptor signaling attenuates respiratory syncytial virus-induced type 2 responses and immunopathology.

Literature DB >> 29678751

Glucagon-like peptide 1 receptor signaling attenuates respiratory syncytial virus-induced type 2 responses and immunopathology.

Melissa H Bloodworth¹, Mark Rusznak², Connor C Pfister², Jian Zhang², Lisa Bastarache³, Sandra Alvarez Calvillo⁴, James D Chappell⁴, Kelli L Boyd¹, Shinji Toki², Dawn C Newcomb⁵, Matthew T Stier¹, Weisong Zhou², Kasia Goleniewska², Martin L Moore⁶, Tina V Hartert², Kevin D Niswender⁷, R Stokes Peebles⁸.

Abstract

Entities: Chemical Disease Gene Mutation Species

Mesh：

Substances：

Year: 2018 PMID： 29678751 PMCID： PMC6078807 DOI： 10.1016/j.jaci.2018.01.053

Source DB: PubMed Journal: J Allergy Clin Immunol ISSN： 0091-6749 Impact factor: 10.793

× No keyword cloud information.

9 in total

Review 1. Pharmacology, physiology, and mechanisms of incretin hormone action.

Authors: Jonathan E Campbell; Daniel J Drucker
Journal: Cell Metab Date: 2013-05-16 Impact factor: 27.287

Review 2. The immunology of asthma: Asthma phenotypes and their implications for personalized treatment.

Authors: Larry Borish
Journal: Ann Allergy Asthma Immunol Date: 2016-08 Impact factor: 6.347

3. The histopathology of fatal untreated human respiratory syncytial virus infection.

Authors: Joyce E Johnson; Ricardo A Gonzales; Sandy J Olson; Peter F Wright; Barney S Graham
Journal: Mod Pathol Date: 2006-11-24 Impact factor: 7.842

4. Respiratory syncytial virus load predicts disease severity in previously healthy infants.

Authors: John P DeVincenzo; Chadi M El Saleeby; Andrew J Bush
Journal: J Infect Dis Date: 2005-04-21 Impact factor: 5.226

5. Glucagon-like peptide-1 analogue therapy for psoriasis patients with obesity and type 2 diabetes: a prospective cohort study.

Authors: T Ahern; A-M Tobin; M Corrigan; A Hogan; C Sweeney; B Kirby; D O'Shea
Journal: J Eur Acad Dermatol Venereol Date: 2012-06-13 Impact factor: 6.166

6. Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data.

Authors: Joshua C Denny; Lisa Bastarache; Marylyn D Ritchie; Robert J Carroll; Raquel Zink; Jonathan D Mosley; Julie R Field; Jill M Pulley; Andrea H Ramirez; Erica Bowton; Melissa A Basford; David S Carrell; Peggy L Peissig; Abel N Kho; Jennifer A Pacheco; Luke V Rasmussen; David R Crosslin; Paul K Crane; Jyotishman Pathak; Suzette J Bielinski; Sarah A Pendergrass; Hua Xu; Lucia A Hindorff; Rongling Li; Teri A Manolio; Christopher G Chute; Rex L Chisholm; Eric B Larson; Gail P Jarvik; Murray H Brilliant; Catherine A McCarty; Iftikhar J Kullo; Jonathan L Haines; Dana C Crawford; Daniel R Masys; Dan M Roden
Journal: Nat Biotechnol Date: 2013-12 Impact factor: 54.908

7. Gene variants in the novel type 2 diabetes loci CDC123/CAMK1D, THADA, ADAMTS9, BCL11A, and MTNR1B affect different aspects of pancreatic beta-cell function.

Authors: Annemarie M Simonis-Bik; Giel Nijpels; Timon W van Haeften; Jeanine J Houwing-Duistermaat; Dorret I Boomsma; Erwin Reiling; Els C van Hove; Michaela Diamant; Mark H H Kramer; Robert J Heine; J Antonie Maassen; P Eline Slagboom; Gonneke Willemsen; Jacqueline M Dekker; Elisabeth M Eekhoff; Eco J de Geus; Leen M 't Hart
Journal: Diabetes Date: 2009-10-15 Impact factor: 9.461

8. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.

Authors: Steven P Marso; Gilbert H Daniels; Kirstine Brown-Frandsen; Peter Kristensen; Johannes F E Mann; Michael A Nauck; Steven E Nissen; Stuart Pocock; Neil R Poulter; Lasse S Ravn; William M Steinberg; Mette Stockner; Bernard Zinman; Richard M Bergenstal; John B Buse
Journal: N Engl J Med Date: 2016-06-13 Impact factor: 176.079

9. Glucagon Like Peptide-1 (GLP-1) Modulates OVA-Induced Airway Inflammation and Mucus Secretion Involving a Protein Kinase A (PKA)-Dependent Nuclear Factor-κB (NF-κB) Signaling Pathway in Mice.

Authors: Tao Zhu; Xiao-Ling Wu; Wei Zhang; Min Xiao
Journal: Int J Mol Sci Date: 2015-08-26 Impact factor: 5.923

9 in total

12 in total

Glucagon-like peptide 1 receptor signaling attenuates respiratory syncytial virus-induced type 2 responses and immunopathology.

Review 1. Pharmacology, physiology, and mechanisms of incretin hormone action.

Review 2. The immunology of asthma: Asthma phenotypes and their implications for personalized treatment.

3. The histopathology of fatal untreated human respiratory syncytial virus infection.

4. Respiratory syncytial virus load predicts disease severity in previously healthy infants.

5. Glucagon-like peptide-1 analogue therapy for psoriasis patients with obesity and type 2 diabetes: a prospective cohort study.

6. Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data.

7. Gene variants in the novel type 2 diabetes loci CDC123/CAMK1D, THADA, ADAMTS9, BCL11A, and MTNR1B affect different aspects of pancreatic beta-cell function.

8. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.

9. Glucagon Like Peptide-1 (GLP-1) Modulates OVA-Induced Airway Inflammation and Mucus Secretion Involving a Protein Kinase A (PKA)-Dependent Nuclear Factor-κB (NF-κB) Signaling Pathway in Mice.

Review 1. Dissecting the interaction between COVID-19 and diabetes mellitus.

Review 2. Evaluating the glucagon-like peptide-1 receptor in managing asthma.

3. Epithelial miR-206 targets CD39/extracellular ATP to upregulate airway IL-25 and TSLP in type 2-high asthma.

4. The GLP-1 receptor in airway inflammation in asthma: a promising novel target?

Review 5. Covid-19 and Diabetes: A Complex Bidirectional Relationship.

Review 6. Perspectives of Antidiabetic Drugs in Diabetes With Coronavirus Infections.

7. Asthma Exacerbations in Patients with Type 2 Diabetes and Asthma on Glucagon-like Peptide-1 Receptor Agonists.

Review 8. COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course.

Review 9. Hypothesized mechanisms explaining poor prognosis in type 2 diabetes patients with COVID-19: a review.

Review 10. Innate Type 2 Responses to Respiratory Syncytial Virus Infection.